Zobrazeno 1 - 10
of 27
pro vyhledávání: '"William Garrard"'
Autor:
Brian Williams, Jennifer Holder-Murray, Kathirvel Subramaniam, Kert Viele, Oscar C Marroquin, Scott Berry, Aman Mahajan, Luca La Colla, Charles Luke, Alison R Althans, Stephen A Esper, Joshua Knight, Joseph Derenzo, Ryan Ball, Shawn Beaman, Nicholas Schott, Elizabeth Lorenzi, Lindsay R Berry, Miranda Masters, Katie A Meister, Todd Wilkinson, William Garrard
Publikováno v:
BMJ Open, Vol 13, Iss 12 (2023)
Introduction Implementation of enhanced recovery pathways (ERPs) has resulted in improved patient-centred outcomes and decreased costs. However, there is a lack of high-level evidence for many ERP elements. We have designed a randomised, embedded, mu
Externí odkaz:
https://doaj.org/article/a50d33e7c3104d919c0bbd8d8932ed41
Autor:
Toluwa D. Omole, Jianuhi Zhu, William Garrard, Floyd W. Thoma, Suresh Mulukutla, Annie McDermott, Brandon M. Herbert, Utibe R. Essien, Jared W. Magnani
Publikováno v:
American Journal of Preventive Cardiology, Vol 10, Iss , Pp 100346- (2022)
Objective: Oral anticoagulation is a standard of care for thromboembolic stroke prevention in individuals with atrial fibrillation (AF). Social determinants of health have had limited investigation in AF and particularly in access to anticoagulation.
Externí odkaz:
https://doaj.org/article/ace80edae0c7432997851ef44a1e26ca
Autor:
Amber E. Johnson, Jianhui Zhu, William Garrard, Floyd W. Thoma, Suresh Mulukutla, Kiarri N. Kershaw, Jared W. Magnani
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 13 (2021)
Background Assessment of the social determinants of post‐hospital cardiac care is needed. We examined the association and predictive ability of neighborhood‐level determinants (area deprivation index, ADI), readmission risk, and mortality for hea
Externí odkaz:
https://doaj.org/article/1f74f04b82e44a2ab48794b2d58949f7
Autor:
Kevin E. Kip, Erin K. McCreary, Kevin Collins, Tami E. Minnier, Graham M. Snyder, William Garrard, Jeffrey C. McKibben, Donald M. Yealy, Christopher W. Seymour, David T. Huang, J. Ryan Bariola, Mark Schmidhofer, Richard J. Wadas, Derek C. Angus, Paula L. Kip, Oscar C. Marroquin
Publikováno v:
Annals of Internal Medicine. 176:496-504
Publikováno v:
American journal of obstetricsgynecology MFM. 5(1)
Postpartum hypertension is the leading cause of postpartum readmission and has long-lasting cardiovascular effects. Black patients have higher incidence rates of hypertensive disorders after delivery and subsequent severe maternal morbidity. Neighbor
Autor:
Erin K. McCreary, J. Ryan Bariola, Richard J. Wadas, Judith A. Shovel, Mary Kay Wisniewski, Michelle Adam, Debbie Albin, Tami Minnier, Mark Schmidhofer, Russell Meyers, Oscar C. Marroquin, Kevin Collins, William Garrard, Lindsay R. Berry, Scott Berry, Amy M. Crawford, Anna McGlothlin, Kelsey Linstrum, Anna Nakayama, Stephanie K. Montgomery, Graham M. Snyder, Donald M. Yealy, Derek C. Angus, Paula L. Kip, Christopher W. Seymour, David T. Huang, Kevin E. Kip
Publikováno v:
JAMA network open. 5(4)
Monoclonal antibody (mAb) treatment decreases hospitalization and death in high-risk outpatients with mild to moderate COVID-19; however, only intravenous administration has been evaluated in randomized clinical trials of treatment. Subcutaneous admi
Autor:
Toluwa D Omole, William Garrard, Suresh R Mulukutla, Floyd W Thoma, Jianhui Zhu, Jared W Magnani
Publikováno v:
Circulation. 145
Introduction: Oral anticoagulation (OAC) is a standard of care for stroke prevention in individuals with atrial fibrillation (AF). Social determinants of health have had limited investigation in AF and particularly in relation to OAC. We examined the
Autor:
Erin K. McCreary, J. Ryan Bariola, Tami E. Minnier, Richard J. Wadas, Judith A. Shovel, Debbie Albin, Oscar C. Marroquin, Kevin E. Kip, Kevin Collins, Mark Schmidhofer, Mary Kay Wisniewski, David A. Nace, Colleen Sullivan, Meredith Axe, Russell Meyers, Alexandra Weissman, William Garrard, Octavia M. Peck-Palmer, Alan Wells, Robert D. Bart, Anne Yang, Lindsay R. Berry, Scott Berry, Amy M. Crawford, Anna McGlothlin, Tina Khadem, Kelsey Linstrum, Stephanie K. Montgomery, Daniel Ricketts, Jason N. Kennedy, Caroline J. Pidro, Ghady Haidar, Graham M. Snyder, Bryan J. McVerry, Donald M. Yealy, Derek C. Angus, Anna Nakayama, Rachel L. Zapf, Paula L. Kip, Christopher W. Seymour, David T. Huang
Publikováno v:
Contemporary clinical trials. 119
Monoclonal antibodies (mAb) that neutralize SARS-CoV-2 decrease hospitalization and death compared to placebo in patients with mild to moderate COVID-19; however, comparative effectiveness is unknown. We report the comparative effectiveness of bamlan
Autor:
David T. Huang, Erin K. McCreary, J. Ryan Bariola, Tami E. Minnier, Richard J. Wadas, Judith A. Shovel, Debbie Albin, Oscar C. Marroquin, Kevin E. Kip, Kevin Collins, Mark Schmidhofer, Mary Kay Wisniewski, David A. Nace, Colleen Sullivan, Meredith Axe, Russell Meyers, Alexandra Weissman, William Garrard, Octavia M. Peck-Palmer, Alan Wells, Robert D. Bart, Anne Yang, Lindsay R. Berry, Scott Berry, Amy M. Crawford, Anna McGlothlin, Tina Khadem, Kelsey Linstrum, Stephanie K. Montgomery, Daniel Ricketts, Jason N. Kennedy, Caroline J. Pidro, Rachel L. Zapf, Paula L. Kip, Ghady Haidar, Graham M. Snyder, Bryan J. McVerry, Donald M. Yealy, Derek C. Angus, Christopher W. Seymour
IMPORTANCEThe effectiveness of monoclonal antibodies (mAbs), casirivimab and imdevimab, and sotrovimab, for patients with mild to moderate COVID-19 from the Delta variant is unknown.OBJECTIVETo evaluate the effectiveness of mAbs for the Delta variant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48ad3dc1fcec7da4462d0339f3315cd0
https://doi.org/10.1101/2021.12.23.21268244
https://doi.org/10.1101/2021.12.23.21268244
Autor:
Richard J. Wadas, Mary Kay Wisniewski, Lindsay R. Berrry, Scott M. Berry, Anna McGlothlin, Anna Nakayama, Christopher W. Seymour, Judith A Shovel, Donald M. Yealy, Mark Schmidhofer, Erin K McCreary, Kevin E. Kip, Tami Minnier, Stephanie K. Montgomery, Derek C. Angus, David T. Huang, Kelsey Linstrum, William Garrard, Paula L Kip, Oscar C. Marroquin, Debbie Albin, Kevin Collins, Michelle Adam, Graham M. Snyder, Russell Meyers, Amy M. Crawford, J Ryan Bariola
ImportanceMonoclonal antibody (mAb) treatment decreases hospitalization and death in outpatients with mild to moderate COVID-19; however, only intravenous administration has been evaluated in randomized clinical trials of treatment. Subcutaneous admi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d9b8ba79e9a9f2e325d1ad2e5b301ba
https://doi.org/10.1101/2021.11.30.21266756
https://doi.org/10.1101/2021.11.30.21266756